Home
>
National Drug Code (NDC)
>
Dyrenium
Dyrenium - 65197-003-01 - (Triamterene)
Drug Information of Dyrenium
| Product NDC: | 65197-003 |
| Proprietary Name: | Dyrenium |
| Non Proprietary Name: | Triamterene |
| Active Ingredient(s): | 100 mg/1 & nbsp; Triamterene |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dyrenium
| Product NDC: | 65197-003 |
| Labeler Name: | WellSpring Pharmaceutical Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013174 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990101 |
Package Information of Dyrenium
| Package NDC: | 65197-003-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (65197-003-01) |
NDC Information of Dyrenium
| NDC Code | 65197-003-01 |
| Proprietary Name | Dyrenium |
| Package Description | 100 CAPSULE in 1 BOTTLE (65197-003-01) |
| Product NDC | 65197-003 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Triamterene |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19990101 |
| Marketing Category Name | NDA |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Substance Name | TRIAMTERENE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC] |
